Post-COVID-19 Guillain-Barré Syndrome: A case report from Oman

Area of Science:

• Neurology
• Infectious Diseases
• Immunology

Background:

• COVID-19, caused by SARS-CoV-2, has been associated with various neurological complications.
• Guillain-Barré syndrome (GBS) is a rare but recognized neurological manifestation following viral infections.

Observation:

• A 72-year-old male presented with progressive bilateral limb weakness and numbness in 2020.
• The patient's symptoms were consistent with GBS, occurring after a COVID-19 infection.

Findings:

• After excluding other causes, a diagnosis of COVID-19-induced GBS was established.
• The patient received a five-day course of intravenous immunoglobulin (IVIG) therapy.
• The case highlights the clinical presentation and management of GBS following SARS-CoV-2 infection.

Implications:

• This case underscores the importance of considering GBS in patients with neurological symptoms post-COVID-19.
• Further research is necessary to understand the spectrum of neuromuscular disorders associated with COVID-19.
• Early diagnosis and treatment, such as IVIG, may be crucial for managing GBS in this context.